CI
信諾 Cigna Group
-2.31 (-0.82%)278.14USD298K成交股數73.5B市值11.5本益比(近四季)0.3股價營收比+6.7%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 71.7B+7% | 68.5B+5% | 72.5B+14% | 69.7B+15% | 67.2B+17% | 65.5B+28% | 63.7B+30% | 60.5B+25% | 57.3B | 51.1B | 49.0B | 48.6B |
| 營業成本 | 56.7B | 54.1B | 57.8B | 55.5B | 53.3B | 48.4B | 47.6B | 44.5B | 41.4B | 35.3B | 33.6B | 33.4B |
| 毛利 | 15.0B+8% | 14.4B-16% | 14.7B-9% | 14.2B-11% | 13.9B-12% | 17.1B+8% | 16.1B+5% | 16.0B+6% | 15.8B | 15.9B | 15.4B | 15.1B |
| 毛利率 | 20.9% | 21.0% | 20.3% | 20.4% | 20.7% | 26.1% | 25.3% | 26.5% | 27.6% | 31.0% | 31.4% | 31.2% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 3.5B | 3.7B | 3.6B | 3.4B | 3.4B | 4.2B | 3.6B | 3.7B | 3.7B | 4.1B | 3.8B | 3.4B |
| 營業利益 | 2.7B+16% | 2.4B+20% | 2.3B-9% | 2.6B+7% | 2.3B+2% | 2.0B-4% | 2.6B+15% | 2.4B+9% | 2.3B | 2.1B | 2.2B | 2.2B |
| 營業利益率 | 3.7% | 3.4% | 3.2% | 3.7% | 3.4% | 3.0% | 4.0% | 4.0% | 3.9% | 4.0% | 4.6% | 4.6% |
| 稅後淨利 | 1.7B+8% | 1.7B+25% | 1.1B+37% | 2.0B+21% | 1.5B-823% | 1.3B+47% | 825M-43% | 1.6B+8% | −212M | 899M | 1.4B | 1.5B |
| 淨利率 | 2.3% | 2.4% | 1.6% | 2.8% | 2.3% | 2.0% | 1.3% | 2.7% | -0.4% | 1.8% | 3.0% | 3.1% |
| 稀釋 EPS | 6.29+10% | 6.26+29% | 4.64+76% | 6.98+28% | 5.71-689% | 4.85+39% | 2.63-45% | 5.45+11% | -0.97 | 3.49 | 4.74 | 4.92 |
| 稀釋股數 | 264M | 264M | 269M | 268M | 268M | 273M | 281M | 284M | 286M | 297M | 297M | 297M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 6.3B | 7.0B | 7.7B | 6.0B | 4.3B | 8.3B | 5.9B | 6.8B | 8.4B | 7.8B | 8.5B | 9.6B |
| 應收帳款 | 30.8B | 26.6B | 28.8B | 31.7B | 31.1B | 26.9B | 27.8B | 25.1B | 20.6B | 17.7B | 19.1B | 18.3B |
| 存貨 | 5.8B | 5.8B | 7.3B | 5.6B | 6.0B | 5.2B | 5.1B | 5.2B | 4.6B | 5.6B | 4.4B | 4.5B |
| 總資產 | 157B | 153B | 158B | 158B | 152B | 151B | 158B | 155B | 153B | 153B | 150B | 150B |
| 有息負債 | 29.1B | 29.4B | 30.9B | 30.9B | 26.5B | 26.5B | 30.2B | 30.2B | 31.1B | 28.2B | 28.1B | 28.1B |
| 總負債 | 114B | 111B | 116B | 116B | 111B | 110B | 115B | 114B | 112B | 106B | 104B | 105B |
| 股東權益 | 42.6B | 42.2B | 41.7B | 41.8B | 40.2B | 40.2B | 42.1B | 41.3B | 41.2B | 46.2B | 45.7B | 45.4B |
| 負債比 | 72.7% | 72.3% | 73.5% | 73.4% | 73.3% | 73.2% | 73.2% | 73.3% | 73.0% | 69.7% | 69.4% | 69.7% |
| 淨現金(現金 − 有息負債) | −22.8B | −22.3B | −23.2B | −24.9B | −22.2B | −18.1B | −24.3B | −23.4B | −22.6B | −20.3B | −19.6B | −18.5B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 1.1B-41% | – | – | – | 1.9B | – | – | 4.8B | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 655M | 650M | 722M | 697M | 682M | 674M | 650M | 738M | 741M | – | – | – |
| 買回庫藏股 | – | 0.00 | – | – | – | 1.5B | – | – | 4.0B | – | – | – |
| 現金股利 | – | 417M | – | – | – | 412M | – | – | 401M | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 283B
| Evernorth | 235B | 83.0% | +16.3% |
|---|---|---|---|
| Cigna Healthcare | 47.4B | 16.8% | -10.7% |
| All Other Segments | 674M | 0.2% | -18.6% |
產品／服務2025 年度 · 251B
| 產品 | 217B | 86.3% | +16.9% |
|---|---|---|---|
| 服務 | 16.9B | 6.7% | +14.4% |
| Service Fees And Other Revenues | 16.9B | 6.7% | +14.4% |
| Service Other | 696M | 0.3% | +19.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 275B | +11.2% | 6.0B | 2.2% | 22.18 | – |
| FY2024 | 247B | +26.6% | 3.4B | 1.4% | 12.12 | – |
| FY2023 | 195B | +8.2% | 5.2B | 2.6% | 17.39 | – |
| FY2022 | 181B | +3.7% | 6.8B | 3.8% | 21.41 | – |
| FY2021 | 174B | +8.5% | 5.4B | 3.1% | 15.75 | – |
| FY2020 | 160B | +4.5% | 8.5B | 5.3% | 22.96 | – |
| FY2019 | 154B | +215.7% | 5.1B | 3.3% | 13.44 | 8.4B |
| FY2018 | 48.7B | – | 2.6B | 5.4% | 10.54 | 3.2B |